Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
December 31, 2015
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
Conditions
Cystic Fibrosis (CF)
Interventions
DRUG
AIR DNase
DRUG
Placebo
Trial Locations (1)
Unknown
Sourasky Medical Center, Tel Aviv
All Listed Sponsors
lead
Protalix
INDUSTRY
NCT02605590 - Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter